Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Linyan Meng(Baylor Genetics), Frank Rigo(Ionis Pharmaceuticals (United States)), Arthur L. Beaudet(Lunar and Planetary Institute), Seung Chun(Ionis Pharmaceuticals (United States)), C. Frank Bennett(Pennsylvania State University), Amanda J. Ward(Ionis Pharmaceuticals (United States))
Cited by 526
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
|New England Journal of Medicine|2013|2k
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
|Nature Genetics|1993|1.7k